PER
Click for more information
0.63% 8.1¢ percheron therapeutics limited

Ann: MHRA approval for ATL1102 Phase IIb DMD clinical trial in UK

  1. ASX News
    lightbulb Created with Sketch. 851
    clock Created with Sketch.
    27/06/23
    16:06
    Post #: 68494498
    Likes Created with Sketch. 38  Upvote
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

JAV Javelin increases the resource of Coogee in WA by 158%
right-arrow Created with Sketch.
NEWS HotCopper's top watched; Oz banks cut saver interest; Kamala’s 28% corporate tax; AI’s back
right-arrow Created with Sketch.
NEWS Dale Gillham's weekly wrap: responding to a weak iron ore price with investing decisions
right-arrow Created with Sketch.
NEWS The business of sport: Warren Tredrea's take on this week's news
right-arrow Created with Sketch.
RDN Raiden gears up for exploration in final quarter of 2024
right-arrow Created with Sketch.
KPO KALiNA Power inks MOU for natgas powered data centres using carbon capture as AI energy use grows
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.1¢ 		Change
0.001(0.63%) 		Mkt cap ! $72.57M
Open High Low Value Volume
8.0¢ 8.1¢ 8.0¢ $89.41K 1.110M

Buyers (Bids)

No. Vol. Price($)
2 90281 8.0¢
 

Sellers (Offers)

Price($) Vol. No.
8.1¢ 58257 1
View Market Depth
Last trade - 10.48am 26/08/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.